tiprankstipranks
Aardvark Therapeutics, Inc. (AARD)
NASDAQ:AARD
US Market
AARD
Aardvark Therapeutics, Inc.
RESEARCH TOOLSreports
Want to see AARD full AI Analyst Report?

Aardvark Therapeutics, Inc. (AARD) Stock News & Sentiment

153 Followers
FDA Clinical Hold, Competitive Pressure Drive Aardvark Therapeutics Downgrade as Price Target Slashed from $18 to $4
Premium
Ratings
FDA Clinical Hold, Competitive Pressure Drive Aardvark Therapeutics Downgrade as Price Target Slashed from $18 to $4
2d ago
AARD
FDA Clinical Hold Halts Aardvark’s ARD-101 Late-Stage Program
Premium
Company Announcements
FDA Clinical Hold Halts Aardvark’s ARD-101 Late-Stage Program
5d ago
8K
AARD
Options Volatility and Implied Earnings Moves Today, April 06, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves Today, April 06, 2026
1M ago
AARD
AIRS
Options Volatility and Implied Earnings Moves This Week, April 06 – April 10, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves This Week, April 06 – April 10, 2026
1M ago
BB
BLK
AARD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
AARD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
AARD
Aardvark Therapeutics Establishes $150 Million Equity Program
Premium
Company Announcements
Aardvark Therapeutics Establishes $150 Million Equity Program
2M ago
8K
AARD
Balancing Safety Concerns and Long-Term Opportunity: Justifying a Buy Rating on Aardvark Amid ARD-101 Clinical Risks
Premium
Ratings
Balancing Safety Concerns and Long-Term Opportunity: Justifying a Buy Rating on Aardvark Amid ARD-101 Clinical Risks
2M ago
AARD
More AARD News >

AARD News on the Web

FDA Clinical Hold, Competitive Pressure Drive Aardvark Therapeutics Downgrade as Price Target Slashed from $18 to $4
TipRanks News
Bearish
Aardvark Therapeutics downgraded to Underperform from Buy at BofA
TipRanks News
Bearish
Aardvark Therapeutics price target lowered to $7 from $8 at B. Riley
TipRanks News
Bearish
Aardvark Therapeutics Inc trading halted, volatility trading pause
TipRanks News
Bearish
Aardvark Therapeutics Inc trading resumes
TipRanks News
Bearish
Aardvark Therapeutics downgraded to Neutral from Buy at BTIG
TipRanks News
Bearish
AARD Stock Plummets 30.2% Amid U.S.-China Talks
GuruFocus News
Bearish
Aardvark Therapeutics to Unblind HERO and OLE Data as FDA Places Full Clinical Hold on ARD-101 Trials
Market Chameleon
Neutral

News Score - Last 7 Days

Very Positive
AARD
Sector Average
Media Buzz
This Week12 articles
Weekly Average1.25 articles
News Sentiment
This Week19%
Sector Average77%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AARD’s Media Buzz Sentiment?
12 articles about AARD were published this week. In an average week, 1.25 articles are published.
    What is AARD’s weekly average amount of articles?
    In an average week, 1.25 articles about AARD are published.
      What is AARD’s News Sentiment?
      19% of articles about AARD were positive this week, compared to its sector average of 77%.
        Healthcare Stocks that are Trending in the News
        DOCSDoximity
        AVAHAveanna Healthcare Holdings
        GOSSGossamer Bio
        CGENCompugen
        SPISpire Healthcare
        Showing the stocks with the most bullish news sentiment over the past week